GL1X · GenesisL1 explorer

Research workbench

Structure of the enoyl-acp reductase of mycobacterium tuberculosis inha, inhibited with the active metabolite of isoniazid

Analyse Structure of the enoyl-acp reductase of mycobacterium tuberculosis inha… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4TRO
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
M9TGV3
Ligands
NAD, ZID, NA
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26847% helix, 16% strandM9TGV3

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • ZID · Isonicotinic-acetyl-nicotinamide-adenine dinucleotide · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 4 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16580.780.8352NAD, ZID
2840.390.7713empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4TRO · Structure of the enoyl-ACP reductase of Mycobacterium tuberculosis InhA, inhibited with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.